Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma.
Journal: Scientific reports
Published: September 08, 2025
Dinaciclib improves treatment response in chemoresistant hepatoblastoma.
Journal: Scientific reports
Published: August 15, 2025
Oncogenic Role of Aberrant EZH2 in Hepatoblastoma.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Asynchronous transitions from high-risk hepatoblastoma to carcinoma.
Journal: Journal of hepatology
Published: April 15, 2025
Showing 1-4 of 4
Last Updated: 09/26/2026